These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 29295495)

  • 1. Rethinking the Combination of Proton Exchanger Inhibitors in Cancer Therapy.
    Iessi E; Logozzi M; Mizzoni D; Di Raimo R; Supuran CT; Fais S
    Metabolites; 2017 Dec; 8(1):. PubMed ID: 29295495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton channels and exchangers in cancer.
    Spugnini EP; Sonveaux P; Stock C; Perez-Sayans M; De Milito A; Avnet S; Garcìa AG; Harguindey S; Fais S
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2715-26. PubMed ID: 25449995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor acidity, chemoresistance and proton pump inhibitors.
    De Milito A; Fais S
    Future Oncol; 2005 Dec; 1(6):779-86. PubMed ID: 16556057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of pH regulators in the diagnosis, prognosis and treatment of cancer.
    Granja S; Tavares-Valente D; Queirós O; Baltazar F
    Semin Cancer Biol; 2017 Apr; 43():17-34. PubMed ID: 28065864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissecting the Proton Transport Pathway in Oral Squamous Cell Carcinoma: State of the Art and Theranostics Implications.
    Lorenzo-Pouso AI; Pérez-Sayáns M; Rodríguez-Zorrilla S; Chamorro-Petronacci C; García-García A
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31470498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular machineries of pH dysregulation in tumor microenvironment: potential targets for cancer therapy.
    Asgharzadeh MR; Barar J; Pourseif MM; Eskandani M; Jafari Niya M; Mashayekhi MR; Omidi Y
    Bioimpacts; 2017; 7(2):115-133. PubMed ID: 28752076
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of proton dynamics in the development and maintenance of multidrug resistance in cancer.
    Daniel C; Bell C; Burton C; Harguindey S; Reshkin SJ; Rauch C
    Biochim Biophys Acta; 2013 May; 1832(5):606-17. PubMed ID: 23376112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renewed interests in carbonic anhydrase IX in relevance to breast cancer treatment.
    Dolatkhah M; Omidi Y
    Bioimpacts; 2019; 9(4):195-197. PubMed ID: 31799155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acidic extracellular microenvironment and cancer.
    Kato Y; Ozawa S; Miyamoto C; Maehata Y; Suzuki A; Maeda T; Baba Y
    Cancer Cell Int; 2013 Sep; 13(1):89. PubMed ID: 24004445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells.
    Mboge MY; Chen Z; Khokhar D; Wolff A; Ai L; Heldermon CD; Bozdag M; Carta F; Supuran CT; Brown KD; McKenna R; Frost CJ; Frost SC
    Biochem J; 2019 May; 476(10):1497-1513. PubMed ID: 31072911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of tumour pH on cancer progression: strategies for clinical intervention.
    Ward C; Meehan J; Gray ME; Murray AF; Argyle DJ; Kunkler IH; Langdon SP
    Explor Target Antitumor Ther; 2020; 1(2):71-100. PubMed ID: 36046070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advances In Developing Novel Anti-Cancer Drugs Targeting Tumor Hypoxic and Acidic Microenvironments.
    Li W; Sun X
    Recent Pat Anticancer Drug Discov; 2018; 13(4):455-468. PubMed ID: 30173649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic disruption of the pHi-regulating proteins Na+/H+ exchanger 1 (SLC9A1) and carbonic anhydrase 9 severely reduces growth of colon cancer cells.
    Parks SK; Cormerais Y; Durivault J; Pouyssegur J
    Oncotarget; 2017 Feb; 8(6):10225-10237. PubMed ID: 28055960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH Gradient Reversal: An Emerging Hallmark of Cancers.
    Sharma M; Astekar M; Soi S; Manjunatha BS; Shetty DC; Radhakrishnan R
    Recent Pat Anticancer Drug Discov; 2015; 10(3):244-58. PubMed ID: 26152150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of V-ATPase and carbonic anhydrases as interference strategy with tumor acidification processes.
    Perez-Sayans M; Garcia-Garcia A; Scozzafava A; Supuran CT
    Curr Pharm Des; 2012; 18(10):1407-13. PubMed ID: 22360559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elucidation of how cancer cells avoid acidosis through comparative transcriptomic data analysis.
    Xu K; Mao X; Mehta M; Cui J; Zhang C; Mao F; Xu Y
    PLoS One; 2013; 8(8):e71177. PubMed ID: 23967163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach.
    Taylor S; Spugnini EP; Assaraf YG; Azzarito T; Rauch C; Fais S
    Drug Resist Updat; 2015 Nov; 23():69-78. PubMed ID: 26341193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling of pH regulation in tumor cells: Direct interaction between proton-coupled lactate transporters and cancer-associated carbonic anhydrase.
    Hiremath SA; Surulescu C; Jamali S; Ames S; Deitmer JW; Becker HM
    Math Biosci Eng; 2018 Dec; 16(1):320-337. PubMed ID: 30674122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 1 Sodium Calcium Exchanger Forms a Complex with Carbonic Anhydrase IX and Via Reverse Mode Activity Contributes to pH Control in Hypoxic Tumors.
    Liskova V; Hudecova S; Lencesova L; Iuliano F; Sirova M; Ondrias K; Pastorekova S; Krizanova O
    Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31395807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nonmainstream approach against cancer.
    Fais S
    J Enzyme Inhib Med Chem; 2016 Dec; 31(6):882-9. PubMed ID: 26972280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.